Resultados de la suprarrenalectomía laparoscópica: técnica convencional vs puerto único laparoscópico / Outcomes of laparoscopic adrenalectomy Conventional technique versus laparo-endoscopic single-site surgery

Objetivo: Analizar nuestros resultados tras 10 años de adrenalectomías laparoscópicas convencionales (LC) y compararlos con los que obtiene la técnica por puerto único (LESS) recientemente introducida en nuestro medio. Material y método: Hemos revisado retrospectivamente los casos de 75 pacientes intervenidos de suprarrenalectomía por el mismo cirujano, por LC o LESS, en nuestro centro entre agosto de 2005 y junio de 2015. Se describen la edad, el sexo, el tamaño, la lateralidad, el diagnóstico preoperatorio, el tiempo quirúrgico, el sangrado intraoperatorio, la reconversión a cirugía abierta, la estancia media, las complicaciones intra y postoperatorias y el resultado anatomopatológico. Se utilizó el test de Fisher y de Chi cuadrado para comparar datos categóricos, y el test de «t» de Student para la comparación de medias con distribución normal. Se consideró significación estadística cuando p < 0,05. Resultados: La técnica de LC fue realizada en 51 pacientes y la LESS en 24. No se obtuvieron resultados estadísticamente significativos en cuanto al tiempo quirúrgico (LC: 103,9 ± 13,21 min vs LESS: 101,46 ± 13,65 min; p = 0,07), sangrado estimado (LC: 258,82 ± 136,92 cc vs LESS: 131,25 ± 36,74 cc; p = 0,46), complicaciones intraoperatorias (5 casos en LC vs ninguno en LESS; p = 0,47) ni posquirúrgicas (2 en el grupo de la LC vs una en el de LESS; p = 0,69) catalogadas según el Sistema Clavien modificado. La estancia hospitalaria fue menor en el caso del LESS (LC: 3,55 ± 0,69 días vs LESS: 2,21 ± 0,31 días; p = 0,01). Conclusiones: La suprarrenalectomía con LC es el abordaje de elección para el tratamiento quirúrgico de la enfermedad adrenal. La técnica LESS es segura y mejora los resultados cosméticos si se realiza por equipos experimentados sin aumentar la morbilidad

Objective: Perform a comparative analysis of the outcomes of conventional laparoscopic adrenalectomy (LC) and the newly introduced laparo-endoscopic single-site surgery (LESS) over ten years. Material and method: We retrospectively reviewed the experience of a single surgeon from our medical centre with laparoscopic adrenalectomy, either through LC or LESS, with 75 patients between August 2005 and June 2015. Here we describe: age, sex, size, lateralization, preoperative diagnosis, total operating time, intraoperative bleeding, conversion to open surgery, mean hospital stay, intra- and postoperative complications and histopathology report. We used Fischer's and the Chi-squared tests to compare categorical data and Student's T-test for a comparison of the means with a normal distribution. Statistical significance was determined when p < 0.05. Results: LC was performed in 51 patients, and LESS in 24 patients. No statistical significance was found for total operating time (LC: 103.9 ± 13.21 min vs. LESS: 101.46 ± 13.65 min; p = 0.07), estimated bleeding (LC: 258.82 ± 136.92cc vs. LESS: 131,25 ± 36,74cc; p = 0.46), intraoperative complications (5 cases in LC, none in LESS; p = 0.47), nor for postoperative complications (two in LC vs. one in LESS; p = 0.69), as catalogued according to the modified Clavien classification system. We detected a statistical significance difference in the comparisons of the mean hospital stay, which was reduced in LESS (LC: 3.55 ± 0.69 days vs. LESS: 2.21 ± 0.31 days; p = 0.01). Conclusions: Adrenalectomy with LC is the approach of choice for surgical treatment of adrenal pathologies. The LESS technique is safe, improves the cosmetic results, and does not increase mortality if performed by experienced teams

Outcomes of laparoscopic adrenalectomy Conventional technique versus laparo-endoscopic single-site surgery. / Resultados de la suprarrenalectomía laparoscópica: técnica convencional vs puerto único laparoscópico.

OBJECTIVE: Perform a comparative analysis of the outcomes of conventional laparoscopic adrenalectomy (LC) and the newly introduced laparo-endoscopic single-site surgery (LESS) over ten years. MATERIAL AND METHOD: We retrospectively reviewed the experience of a single surgeon from our medical centre with laparoscopic adrenalectomy, either through LC or LESS, with 75 patients between August 2005 and June 2015. Here we describe: age, sex, size, lateralization, preoperative diagnosis, total operating time, intraoperative bleeding, conversion to open surgery, mean hospital stay, intra- and postoperative complications and histopathology report. We used Fischer's and the Chi-squared tests to compare categorical data and Student's T-test for a comparison of the means with a normal distribution. Statistical significance was determined when p<0.05. RESULTS: LC was performed in 51 patients, and LESS in 24 patients. No statistical significance was found for total operating time (LC: 103.9±13.21min vs. LESS: 101.46±13.65min; p=0.07), estimated bleeding (LC: 258.82±136.92cc vs. LESS: 131,25±36,74cc; p=0.46), intraoperative complications (5 cases in LC, none in LESS; p=0.47), nor for postoperative complications (two in LC vs. one in LESS; p=0.69), as catalogued according to the modified Clavien classification system. We detected a statistical significance difference in the comparisons of the mean hospital stay, which was reduced in LESS (LC: 3.55±0.69 days vs. LESS: 2.21±0.31 days; p=0.01). CONCLUSIONS: Adrenalectomy with LC is the approach of choice for surgical treatment of adrenal pathologies. The LESS technique is safe, improves the cosmetic results, and does not increase mortality if performed by experienced teams.

[An analysis of our experience in cryopreservation of semen from cancer patients]. / Análisis de nuestra experiencia en la criopreservación del semen en pacientes oncológicos.

OBJECTIVE: To analyze the characteristics of patients with oncological problems who were users of the sperm bank, as well as use of cryopreserved semen. MATERIALS AND METHODS: A retrospective analysis was made of all cryopreserved semen samples from males diagnosed with cancer from April 1992 to October 2007 at the province of Las Palmas. RESULTS: One hundred and one male patients with cancer were referred to the sperm bank before cancer therapy. Eighty percent of them were contacted by telephone. Mean freezing age was 25 years. Forty-one percent of patients had testicular tumors. Thirty-three percent had no prior biological children. Only one patient had known fertility problems before treatment. Sixty-seven percent of patients were warned by the healthcare team about the possibility of infertility at the time of cancer diagnosis. Only 1% of samples were not adequate for cryopreservation. The frozen sample was used by 4% of the patients. When patients were asked about future use of semen, 63% of them wanted to continue with semen cryopreservation, as compared to 17% who had no interest in having offspring in the future. CONCLUSION: The number of fertile patients who cryopreserve semen is extremely low. It is very important that the healthcare team warns patients of potential infertility after treatment. A high proportion of patients have valid samples for cryopreservation, but semen is used by a low number of patients. A high proportion of patients want to maintain their semen frozen.

Análisis de nuestra experiencia en la criopreservación del semen en pacientes oncológicos / An analysis of our experience in cryopreservation of semen from cancer patients

Objetivo: analizar las características de los pacientes con problemas oncológicos, usuarios del banco de semen, así como el uso del semen criopreservado. Material y métodos: de forma restrospectiva se han analizado todas las muestras de semen criopreservadas de varones con el diagnóstico de cáncer, entre abril de 1992 y octubre del 2007, en la provincia de Las Palmas. Resultados: fueron remitidos al banco de semen 101 varones con tumores, previo tratamiento oncológico. Se contactó por vía telefónica con el 80%. La edad media de congelación fue de 25 años. El 41% de los pacientes padecían de tumores testiculares; no tenían hijos biológicos previos el 33%. Sólo un paciente tenía problemas de infertilidad previo al tratamiento. En el momento del diagnóstico del cáncer el equipo sanitario advirtió al 67% de los pacientes de la posibilidad de infertilidad. Sólo el 1% de las muestras no fue apta para la criopreservación. Se usó la muestra congelada en el 4% de las muestras, y cuando se les preguntaba sobre el uso futuro del semen el 63% de los pacientes deseaba continuar con el criopreservado, frente al 17%, que no mostraba interés por tener descendencia en el futuro. Conclusión: el número de enfermos en edad fértil que criopreservan el semen es extremadamente bajo. Advertir a los pacientes de la posibilidad de infertilidad tras el tratamiento, por parte del equipo sanitario, es de una vital importancia. Hay un alto porcentaje de pacientes con muestras válidas para criopreservación, un escaso número de pacientes hacen uso del semen, aunque existe un alto porcentaje de pacientes con deseo de continuar con su semen congelado(AU)

Objective: To analyze the characteristics of patients with oncological problems who were users of the sperm bank, as well as use of cryopreserved semen. Materials and methods: A retrospective analysis was made of all cryopreserved semen samples from males diagnosed with cancer from April 1992 to October 2007 at the province of Las Palmas. Results: One hundred and one male patients with cancer were referred to the sperm bank before cancer therapy. Eighty percent of them were contacted by telephone. Mean freezing age was 25 years. Forty-one percent of patients had testicular tumors. Thirty-three percent had no prior biological children. Only one patient had known fertility problems before treatment. Sixty-seven percent of patients were warned by the healthcare team about the possibility of infertility at the time of cancer diagnosis. Only 1% of samples were not adequate for cryopreservation. The frozen sample was used by 4% of the patients. When patients were asked about future use of semen, 63% of them wanted to continue with semen cryopreservation, as compared to 17% who had no interest in having offspring in the future. Conclusion: The number of fertile patients who cryopreserve semen is extremely low. It is very important that the healthcare team warns patients of potential infertility after treatment. A high proportion of patients have valid samples for cryopreservation, but semen is used by a low number of patients. A high proportion of patients want to maintain their semen frozen(AU)

[Renal artery aneurysm. Laparoscopic nephrectomy, ex-vivo reconstruction and autotrasplantation]. / Aneurisma de arteria renal. Nefrectomía laparoscópica, reconstrucción en banco y autotrasplante.

We report a case of severe hypertensive patient with poor response regardless 5 drugs, that is diagnosed with right renal artery aneurysm, during the study of his HTN. Conservative surgery was performed by extracting laparoscopic kidney graft,ex-vivo pedicle reconstruction, followed by transplant in right iliac fossa utilizing the ilioinguinal incision used for the extraction, without need for two incisions. We perform a brief discussion of surgery indications of surgery in these patients.

Aneurisma de arteria renal. Nefrectomía laparoscópica, reconstrucción en banco y autotrasplante / Renal artery aneurysm. Laparoscopic nephrectomy, ex-vivo reconstruction and autotransplantation

Se presenta un caso de paciente hipertenso severo con mala respuesta a pesar de 5 fármacos, el cual es diagnosticado de aneurisma en arteria renal derecha, durante el estudio de su HTA. Se realiza cirugía conservadora renal haciendo extracción laparoscópica del injerto, reconstrucción en banco del pedículo, y posterior trasplante en fosa ilíaca derecha aprovechado la incisión ilioinguinal empleada para la extracción, sin necesidad de dos incisiones. Se realiza breve discusión de indicaciones de la cirugía en estos pacientes (AU)

We report a case of severe hypertensive patient with poor response regardless 5 drugs, that is diagnosed with right renal artery aneurysm, during the study of his HTN. Conservative surgery was performed by extracting laparoscopic kidney graft, ex-vivo pedicle reconstruction, followed by transplant in right iliac fossa utilizing the ilioinguinal incision used for the extraction, without need for two incisions. We perform a brief discussion of surgery indications of surgery in these patients (AU)

[Clinical-pathology relationship in bladder cancer]. / Relación clinico-patólogica en cáncer vesical.

OBJECTIVES: Analyze the role of the Computerized Axial Tomography (TAC) like image study of pre-surgery stadification, in the subjected patients to radical cystectomy, for the treatment of muscle infiltrate bladder cancer. METHODS: Retrospective study of cohorts on 63 subjected patients to radical cystectomy for bladder cancer, in oneself service, between january of 1995 and december of 2.005. The capacity of the TAC was determined for the stadification bladder (pT), node (pN) and the results were compared, with the obtained ones in the pathological anatomy after the radical cystectomy, acording to TNM clasification. The possible impact of this image technique was evaluated in the change of surgical attitude in these patients. RESULTS: The estimate of bladder affectation with TAC was correct in 28.6%, sub-estadificate in 50.8%, and up-estadificate in 20.6%. The TAC for the bladder possesses a lower sensibility the more outpost it is this affectation. It specificity is higher the more advanced locally is the cancer, oscillating among 44% in the pT2 and 94% in the pT4. Regarding the estadification node, it is correct in 73.5% of all cases, although this percentage depends almost exclusively on the patients with negative node (N -). These data offer us a sensibility of 28%, specificity of 55%, positive predictive value of 68% and negative predictive of 67%. SUMMARY: The impact of the TAC in the clinical estadification of the infiltrate bladder cancer is relatively low. The biggest benefit is obtained in patient with suspicion of advanced illness. Its limitation to this group would suppose a significant reduction of costs, with low risk of an inappropriate surgical handling.

[Early biochemical failure after radical prostatectomy for prostate cancer. Impact factors?]. / Recidiva bioquímica precoz tras prostatectomía radical retropúbica por cáncer de próstata. Factores implicados. Influye el tiempo de espera entre biopsia y cirugía?

UNLABELLED: Does delay from biopsy to surgery have any influence? OBJECTIVES: To determine wether WT may impact on the EBF (before one year) alter RRP in our series, and to study other factors that may impact on this issue. MATERIAL AND METHODS: We study 310 RRP. Inclusion criteria are: one year follow up, no hormonal manipulation neither previous radiotherapy. Patients are divide in two groups attending WT. Group A < 90 days (n: 148), Group B > 90 days (n: 162). We study EBF (2 or more PSA determinations >= 0.2 ng/ml), and the impact of previous PSA, biopsy Gleason, Gleason of the specimen (G), pT stage (pT), and WT. T of Student or W of Wilcoxon are used to determine the homogeneity of the two groups. Chi Square of Pearson to compare the two group's EBF and pT attending to WT and EBF attending to pT. U of Mann Whitney is used to study EBF attending to G. Multivariate logistic regresion (LR) is used to study the impact of the variables on EBF. RESULTS: There are no differences between the two groups in age (p<0.129), PSA (p<0.479), biopsy's Gleason (p<0.913). There are no differences in EBF nor in pT attending to WT. Significant statystical differences are founded in EBF attending to pT and G. T3 tumors have more chance of recurrence than T2. EBF is more frecuent as G increases. In logistic regresion of the global serie, independent variables for progression are: Previous PSA and pT. Nor biopsy's Gleason nor specimen's Gleason, nor WT, impact on the EBF. CONCLUSIONS: Biopsy Gleason and WT do not impact on EBF. WT do not impact on pT. In our serie differences on EBF are lead by previous PSA and pT. Also Gleason of the especimen seems to impact on EBF, but in lower proportion, with no significance in multivariate analysis.

Relación clinico-patólogica en cáncer vesical / Clinical-pathology relationship in bladder cancer

Objetivos: Analizar el papel de la Tomografía Axial Computerizada (TAC) como estudio de estadificación prequirúrgica, en los pacientes sometidos a cistectomía radical, para el tratamiento del carcinoma vesical infiltrante. Métodos: Estudio de cohortes retrospectivo sobre 63 pacientes sometidos a cistectomía radical por carcinoma urotelial de vejiga, en un mismo servicio, entre enero del 1995 y diciembre del 2005. Se determinó la capacidad de la TAC para el estadiaje vesical, ganglionar y se compararon los resultados, con los obtenidos en la anatomía patológica tras la cistectomia radical, según la clasificación TNM, actual. Se evaluó el posible impacto de esta técnica de imagen en el cambio de actitud quirúrgica en estos pacientes. Resultados: La estimación de afectación perivesical con TAC fue correcta en 28,6%, subestadiada en 50,8%, y sobreestadiada en 20,6%. La TAC para el estadiaje perivesical posee una sensibilidad más baja cuanto más avanzada es dicha afectación. Su especificidad es más elevada cuanto más avanzado localmente sea el tumor, oscilando entre 44% en los pT2 y el 94% en los pT4. En lo referente al estadiaje ganglionar, es correcto en 73,5 % de los casos, aunque este porcentaje depende casi exclusivamente de los pacientes con ganglios negativos (N-). Estos datos nos ofrecen una sensibilidad del 28%, especificidad de 55%, valor predictivo positivo de 68% y predictivo negativo de 67%. Conclusiones: El impacto de la TAC en el estadiaje clínico del cáncer vesical infiltrante es relativamente bajo. El mayor beneficio se obtiene en pacientes con sospecha de enfermedad avanzada. Su limitación a este grupo supondría una significativa reducción de costes, con bajo riesgo de un manejo quirúrgico inapropiado (AU)

Objectives: Analyze the role of the Computerized Axial Tomography (TAC) like image study of pre-surgery stadification, in the subjected patients to radical cystectomy, for the treatment of muscle infiltrate bladder cancer. Methods: Retrospective study of cohorts on 63 subjected patients to radical cystectomy for bladder cancer, in oneself service, between january of 1995 and december of 2.005. The capacity of the TAC was determined for the stadification bladder (pT), node (pN) and the results were compared, with the obtained ones in the pathological anatomy after the radical cystectomy, acording to TNM clasification. The possible impact of this image technique was evaluated in the change of surgical attitude in these patients. Results: The estimate of bladder affectation with TAC was correct in 28,6%, sub-estadificate in 50,8%, and up estadificate in 20,6%. The TAC for the bladder possesses a lower sensibility the more outpost it is this affectation. It specificity is higher the more advanced locally is the cancer, oscillating among 44% in the pT2 and 94% in thepT4. Regarding the estadification node, it is correct in 73,5% of all cases, although this percentage depends almost exclusively on the patients with negative node (N -). These data offer us a sensibility of 28%, specificity of 55%, positive predictive value of 68% and negative predictive of 67%. Summary: The impact of the TAC in the clinical estadification of the infiltrate bladder cancer is relatively low. The biggest benefit is obtained in patient with suspicion of advanced illness. Its limitation to this group would suppose a significant reduction of costs, with low risk of an inappropriate surgical handling (AU)

Recidiva bioquímica precoz tras prostatectomía radical retropúbica por cáncer de próstata. Factores implicados. ¿Influye el tiempo de espera entre biopsia y cirugía? / Early biochemical failure radical prostatectomy for prostate cancer. Impact factors?

Objetivos: Estudiar diferentes factores que pueden influir en la recidiva bioquímica precoz (RBP) (primer año tras cirugía), tras prostatectomía radical retropúbica (PRR). Material y métodos: Estudiamos 310 PRR. Criterios de inclusión: al menos un año de seguimiento, ausencia de bloqueo hormonal o radioterapia previa. Los pacientes fueron divididos inicialmente en 2 grupos según el tiempo de espera. Grupo A <90días (n: 148), Grupo B > 90 días (n: 162). Estudiamos RBP (2 o más determinaciones de PSA >= 0,2 ng/ml) y la influencia del PSA previo, el Gleason de la biopsia, el Gleason del espécimen, estadio pT, y tiempo de espera. Para estudiar la homogeneidad existente entre los dos grupos usamos la t de Student o W de Wilcoxon. Estudiamos la RBP y el estadio pT en los dos grupos usando la chi cuadrado de Pearson, que también nos sirve para estudiar en los dos grupos la RBP en relación al estadio pT. El test de la U de mann-Whitney lo usamos para estudiar en la serie global la RBP según el Gleason del espécimen. Por último se realiza una Regresión logística multivariante para estudiar la influencia de todas las variables en la RBP en la serie global. Resultados: No encontramos diferencias entre los dos grupos en edad (p< 0,129), ni PSA (p< 0,479), ni Gleason de biopsia(p<0,913). No se encontraron diferencias en RBP ni en estadio pT según el tiempo de espera. Hallamos diferencias estadísticamente significativas en RBP si estudiamos estadio pT y Gleason de la pieza. Los T3 tienen más incidencia de recurrencia que losT2 y hay más incidencia de RBP según aumenta el Gleason de la pieza. En la regresión logística de la serie global las variables independientes de progresión son: PSA previo y estadio pT. Ni el Gleason de la biopsia ni el Gleason del espécimen, ni el tiempo de espera entre biopsia y cirugía influyen en la RBP. Conclusiones: El Gleason de la biopsia y el tiempo de espera no influyen en la RBP. El tiempo de espera tampoco influye en el estadio T final. En nuestra serie las diferencias en RBP vienen dadas por el PSA previo y pT. El Gleason del espécimen parece influir en la RBP, pero en menor proporción sin significado en el análisis multivariante (au)

Objectives: To determine wether WT may impact on the EBF (before one year) alter RRP in our series, and to study other factors that may impact on this issue. Material and methods: We study 310 RRP. Inclusion criteria are: one year follow up, no hormonal manipulation neither previous radiotherapy. Patients are divide in two groups attending WT. Group A < 90 days (n: 148), Group B > 90 days (n: 162). We study EBF (2 or more PSA determinations >= 0.2 ng/ml), and the impact of previous PSA, biopsy Gleason, Gleason of the specimen (G), pT stage (pT), and WT. T of Student or W of Wilcoxon are used to determine the homogeneity of the two groups. Chi Square of Pearson to compare the two group’s EBF and pT attending to WT and EBF attending to pT. U of Mann Whitney is used to study EBF attending to G. Multivariate logistic regresion (LR) is used to study the impact of the variables on EBF. Results: There are no differences between the two groups in age (p< 0.129), PSA (p< 0.479), biopsy´s Gleason (p<0.913). There are no differences in EBF nor in pT attending to WT. Significant statystical differences are founded in EBF attending to pT and G. T3 tumors have more chance of recurrence than T2. EBF is more frecuent as G increases. In logistic regresion of the global serie, independent variables for progression are: Previous PSA and pT. Nor biopsy´s Gleasonnor specimen´s Gleason, nor WT, impact on the EBF. Conclusions: Biopsy Gleason and WT do not impact on EBF. WT do not impact on pT. In our serie differences on EBF are lead by previous PSA and pT. Also Gleason of the especimen seems to impact on EBF, but in lower proportion, with no significance in multivariate analysis (AU)

Uropatía obstructiva bilateral secundaria a hernia vesical masiva / Bilateral ureterohydronephrosis secondary massive vesical hernia

La hernia vesical no es una patología infrecuente, aparece entre el 0,3 y 3% según los autores. La aparición de hernia vesical masiva constituye una rareza. Presentamos un nuevo caso de fracaso renal secundario a hernia vesical inguinoescrotal con uropatía obstructiva bilateral, analizando la presentación clínica, el esquema diagnostico y el tratamiento de estas hernias (AU)

Bladder hernia is not a rare pathological condition, with a frequency between 0,3 and 3%. Massive bladder hernia is less frequent an very rarely ureterohydronephrosis with this pathology. We will present a case a renal failure secondary to inguinoscrotal bladder hernia with bilateral obstructive uropathy and an analyzed the clinical presentation, the diagnosis and the treatment for those hernias (AU)

[Bladder neoplasm after nephroureterectomy for upper urinary tract tumor. Does distal ureter surgery influx on the evolution?]. / Neoplasia vesical tras nefroureterectomía por tumores de urotelio superior. La cirugía del uréter distal influye en la evolución?

OBJECTIVE: To compare evolution in patients with urothelial upper tract tumor (UUTT) in whom we performed the classic open approach to the distal ureter with those in whom whe performed the endoscopic approach. We study the bladder recurrences in each group and the factors which may influx on the evolution. MATERIAL AND METHODS: Retrospective review of nephroureterectomies in our department in the last 20 years. Group A (n:24): double incision (lumbar and pelvic incision), Group B (n:29): endoscopical approach of the distal ureter and classic lumbar incision. A descriptive study is first performed in which we review: sex, and patients age, background transuretral resection of bladder tumor (TURBT), UUTT side, and UUTT location (calices, pelvis or urether). Pathological stage and tumor grade are also exposed. Secondly, a review of the bladder recurrences in each group is performed. In order to find differences between de groups we used the Fisher's Exact test. RESULTS: We observed that in terms of bladder recurrence there is a statistically significant difference between the two groups favoring Group B (p < 0.036), which means that there are less bladder recidives when perform endoscopic approach of distal ureter. Noneless due to the groups inhomogeneity in tumor stage, grade, and location, this differences seem to be associated to these sigues, more than to the approach to the ureter as an independant variable. In that concerning to the eventual relationship between bladder recidive and background of previous TURBT, we have not found any differences between the two groups but there are statystically significant difference in the global series. The small number of recurrences (13) does not allow us to establish a well based conclusion on this issue, but it seems that the background of previous TURBT is an important factor that may influx in posterior bladder recurrences. CONCLUSIONS: In our results, endoscopic approach of distal ureter in nephroureterectomy for UUTT does seems to positively influx in the posterior chance of bladder recurrences. But the studied sample is small and the two groups have not been aleatorized because of ethical reasons. May the low number of cases affect the test's statistical potency. It seems that previous TURBT may conditionate these recurrences, as we show in global serie. It should be necessary a prospective and statistically analised multicenter trial to understand if distal ureter approach influx on the evolution of these tumors.

Neoplasia vesical tras nefroureterectomía por tumores de urotelio superior. ¿La cirugía del uréter distal influye en la evolución? / Bladder neoplasm after nephroureterectomy for upper urinary tract tumor. Does distal ureter surgery influx on the evolution?

Objetivo. Comparar la evolución de los pacientes con tumor de urotelio superior (TUS) en los cuales realizamos, durante la nefroureterectomía, abordaje clásico abierto de desinserción del uréter distal con aquellos en los que realizamos abordaje endoscópico. Estudiamos el índice de recurrencias vesicales en cada grupo y los factores que pueden influir en la evolución. Material y métodos. Se realiza una revisión retrospectiva de las nefroureterectomías realizadas en nuestro Servicio en los últimos 20 años. Se dividen en dos grupos. Grupo A (n: 29): doble incisión (lumbar y pélvica), Grupo B (n: 24): abordaje endoscópico del uréter distal e incisión lumbar clásica. Se realiza en primer lugar un estudio descriptivo en el que se expone: sexo y edad del paciente, antecedentes de resección vesical previa por tumor (RTU-V), lado del TUS, y localización (cálices, pelvis o uréter). También revisamos estadio patológico y grado tumoral. En segundo lugar se realiza una revisión de las recidivas vesicales en cada grupo. Para establecer posibles diferencias utilizamos el Test exacto de Fisher. Resultados. Observamos diferencias estadísticamente significativas en términos de recurrencias vesicales a favor del grupo B (p<0.036), lo que significa que existen menos recidivas vesicales en nuestra serie en el grupo de cirugía endoscópica. Sin embargo debido a la inhomogeneidad de los grupos en estadio, grado y localización tumoral, esta diferencia parece más bien atribuible a estas características, más que a la vía de abordaje como factor independiente. En lo referente a la relación entre la recidiva vesical y antecedentes de RTU-V no hemos encontrado diferencias entre los grupos pero si existe diferencia en la serie global. El escaso número de recurrencias (13) no nos permite establecer una conclusión clara en este problema, aunque parece que el antecedente de neoplasia previa de vejiga influye en la posibilidad de recurrencia vesical. Conclusiones. En nuestro resultado el abordaje endoscópico en la nefroureterectomía por TUS parece influir en la posterior aparición de menos recidivas en vejiga, sin embargo la muestra es corta y los grupos no son homogéneos porque el abordaje del uréter no se ha aleatorizado por razones éticas obvias. Si parece existir relación entre la existencia de antecedentes de RTU-V y la aparición de recidivas posteriores, como mostramos en la serie global. En cualquier caso son necesarios estudios prospectivos randomizados multicéntricos para conocer si el abordaje del uréter distal influye en la posterior aparición de recidivas vesicales

Objective. To compare evolution in patients with urothelial upper tract tumor (UUTT) in whom we performed the classic open approach to the distal ureter with those in whom whe performed the endoscopic approach. We study the bladder recurrences in each group and the factors which may influx on the evolution. Material and methods. Retrospective review of nephroureterectomies in our department in the last 20 years. Group A (n:24): double incision (lumbar and pelvic incision), Group B (n:29): endoscopical approach of the distal ureter and classic lumbar incision. A descriptive study is first performed in which we review: sex, and patients age, background transuretral resection of bladder tumor (TURBT), UUTT side, and UUTT location (calices, pelvis or urether). Pathological stage and tumor grade are also exposed. Secondly, a review of the bladder recurrences in each group is performed In order to find differences between de groups we used the Fisher´s Exact test. Results. We observed that in terms of bladder recurrence there is a statistically significant difference between the two groups favoring Group B (p< 0.036), which means that there are less bladder recidives when perform endoscopic approach of distal ureter. Noneless due to the groups inhomogeneity in tumor stage, grade, and location, this differences seem to be associated to these sigues, more than to the approach to the ureter as an independant variable. In that concerning to the eventual relationship between bladder recidive and background of previous TURBT, we have not found any differences between the two groups but there are statystically significant difference in the global series. The small number of recurrences (13) does not allow us to establish a well based conclusion on this issue, but it seems that the background of previous TURBT is an important factor that may influx in posterior bladder recurrences. Conclusions. In our results, endoscopic approach of distal ureter in nephroureterectomy for UUTT does seems to positively influx in the posterior chance of bladder recurrences. But the studied sample is small and the two groups have not been aleatorized because of ethical reasons. May the low number of cases affect the test´s statistical potency. It seems that previous TURBT may conditionate these recurrences, as we show in global serie. It should be necessary a prospective and statistically analised multicenter trial to understand if distal ureter approach influx on the evolution of these tumors

[Role of nephrectomy in metastatic renal cell carcinoma. Experience of the Department of Urology Juan Canalejo Hospital]. / Papel de la nefrectomía en el adenocarcinoma renal metastático: experiencia del Servicio de Urología del Hospital Juan Canalejo.

OBJECTIVES: We expose our experience in nephrectomy in metastatic renal cell carcinoma, and also show complications, evolution and survival of these patients. MATERIAL AND METHODS: We performe a retrospective review of renal cell carcinoma treated at our service in the period between January 1st 1991 and December 31st 2002. We only studied those which presented in a metastatic pattern (31), and divide these in two groups: the ones which were nephrectomized and those which were not. We try to showw the differences between the two groups in order of status performance (E.C.O.G.), associated morbidity and median survival. In the first group we also study complications of surgery and treatment that patients underwent. RESULTS: we performed nephrectomy in 19 cases, all of them E.C.O.G. 0-1. Median postoperative stay was 12 days, and complication rate was 11.5%. Of these patients, 45% underwent some type of systemic treatment, and median survival was 31 months. We didn't performed nephrectomy in 12 patients, of which 9 were E.C.O.G. 2-3. Associated co-morbidity was higher in this group. Only in three patients any treatment was offered always with palliative reason. Median survival was 3.8 months. CONCLUSIONS: In those patients with good performance status this approach does not represent more morbility nor mortality than in non-metastatic patients, and that is a cornerstone in their management. We also make a literature review in which we see the last pathways in the management of these patients, and that show the needing for a combined approach both quirurgical and inmunotherapical. We have review with special interest the studie's conclusions of SWOG and EORTC groups.

Papel de la nefrectomía en el adenocarcinoma renal metastático: experiencia del Servicio de Urología del Hospital Juan Canalejo / Role of nephrectomy in metastatic renal cell carcinoma. Experience of the department of urology Juan Canalejo Hospital

Objetivos: Presentar nuestra experiencia en la realización de nefrectomía en tumores renales que se presentan con metástasis al diagnóstico, y observar las complicaciones, evolución y supervivencia de estos pacientes. Material y métodos: Realizamos una revisión retrospectiva de los adenocarcinomas renales en el período entre 1-1-1991 y 31-12-2002. Estudiamos solamente los que se presentaron con metástasis (31). Se estudian aquellos pacientes a los que se les practicó nefrectomía y aquellos a los que no se les ofreció tratamiento quirúrgico. Buscamos mostrar las diferencias en los dos grupos en cuanto a status vital (Tabla E.C.O.G.), patología concomitante y supervivencia media. En el grupo de los pacientes nefrectomizados estudiamos las complicaciones derivadas de la intervención y el tratamiento posterior. Resultados: Realizamos nefrectomía en 19 casos. Todos ellos E.C.O.G. 0-1. La estancia post operatoria media fue de12 días, y la tasa de complicaciones 11,5%. El 45% de estos pacientes siguieron algún tipo de tratamiento posterior, y la supervivencia media fue de 31 meses. No se realizó nefrectomía en 12 casos, de los cuales 9 eran E.C.O. G 2-3. La patología asociada que presentaban estos pacientes era más importante que en el primer grupo. Sólo en 3 casos se administró tratamiento con fines paliativos y la supervivencia media fue de 3,8 meses. Conclusiones: En pacientes con buen estado vital la nefrectomía no representa más morbilidad ni mortalidad que en los pacientes sin metástasis, y nos parece una opción fundamental en su manejo. Realizamos una revisión bibliográfica en la que recogemos las últimas tendencias en el tratamiento de estos pacientes, que ponen de manifiesto la necesidad del abordaje combinado quirúrgico e inmunoterápico. Nos parecen de interés fundamental las conclusiones de los estudios del SWOG y del EORTC (AU)

Objectives: We expose our experience in nephrectomy in metastatic renal cell carcinoma, and also show complications, evolution and survival of these patients. Material and methods: We performe a retrospective review of renal cell carcinomaes treated at our service in the period between January 1st 1991 and December 31st 2002. We only studied those which presented in a metastatic pattern (31), and divide these in two groups: the ones which were nephrectomized and those which were not. We try to show the diferences between the two groups in order of status performance (E.C.O.G.), associated morbidity and median survival. In the first group we also study complications of surgery and treatment that patients underwent. Results: we performed nephrectomy in 19 cases, all of them E.C.O.G. 0-1. Median postoperative stay was 12 days, and complication rate was 11.5%. Of these patients, 45% underwent some tipe of systemic treatment, and median survival was 31 months. We didn´t performed nephrectomy in 12 patients, of which 9 were E.C.O.G. 2-3. Asociated comorbidity was higher in this group. Only in three patients any treatment was offerted always with paliative reason. Median survival was 3.8 months. Conclusions: In those patients with good performance status this aproach does not represent more morbility or mortality than in non- metastatic patients, and that is a cornerstone in their management. We also make a literature review in wich we see the last pathways in the management e of these patients, and that show the needing for a conbined approach both quirurgical and inmunotherapical. We have review with special interest the studie’s conclusions of SWOG and EORTC groups (AU)

[Iatrogenic prostatorectal fistula. Use of gracilis muscle pedicled flap for its reparation. Presentation of two cases]. / Fistula prostatorectal yatrogénica. Reparación con colgajo pediculado de músculo gracilis. Presentación de dos casos.

We present two cases in which during retropubic prostatectomy for benign prostatic disease a prostatorectal fistula ocurred. We describe its reparation using a pedicled flap of gracilis muscle. We also present cystographic and opaque enema images which shows the before and after of this surgery. Patients had good outcome without incontinence nor problems related to muscle desinsertion surgery.